Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Afegostat in Type 1 Gaucher Disease on ERT
NCT00433147Phase 2Completed
- Sponsor
- Amicus Therapeutics
- Start
- Mar 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Afegostat in Gaucher disease type 1 (GD1), sponsored by Amicus Therapeutics. Started Mar 2007; status: completed.
02
Drugs
Afegostat
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00433147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433147.